Knowledge

Penny Moore (virologist)

Source 📝

Virologist

Penelope Moore
Born (1975-04-29) 29 April 1975 (age 49)
Alma materUniversity of Witwatersrand
University of London
Known forHIV research, Covid 19 research, Omicron variant
Scientific career
FieldsVirology
InstitutionsUniversity of the Witwatersrand
NICD
WebsiteProf Moore at WITS

Penelope Moore is a virologist and DST/NRF South African Research Chair of Virus-Host Dynamics at the University of the Witwatersrand in Johannesburg, South Africa and Senior Scientist at the National Institute for Communicable Diseases.

Education and work

Moore received her Master of Science degree in Microbiology from the University of Witwatersrand. In 2003, she completed her PhD in Virology at the University of London.

She was one of the first scientists to bring the Omicron variant of COVID-19 to public attention. She remarked of the pace of the preliminary research that “We’re flying at warp speed.

Her current work focuses on the HIV neutralizing antibodies and their interactions with HIV. These antibodies would form the basis for an HIV vaccine.

Recognition

In 2009, Moore received a Sydney Brenner Fellowship from the Academy of Science of South Africa (ASSAf) and was awarded a Friedel Sellschop Award by the University of the Witwatersrand.

In 2015 while at the Centre for HIV and STI at the NICD and the Wits School of Pathology Moore was awarded the Chair in Virus-Host Dynamics for Public Health at Wits.

In 2018 Moore was awarded a Silver Medal by the South African Medical Research Council for "important scientific contributions made within 10 years of having been awarded PhD."

Moore is a founding member of the South African Young Academy of Science, a full Member of the American Society for Virology and a Member of the ASSAf.

See also

References

  1. "Penny Moore". The Conversation. 26 November 2015. Retrieved 28 November 2021.
  2. ^ The University of the Witwatersrand. "Wits University". Penelope.Moore@wits.ac.za. Retrieved 26 January 2022.
  3. "Penny Moore - Senior Scientist - NICD". LinkedIn. Retrieved 26 January 2022.
  4. ^ "Professor Penny Moore PhD | SANTHE". www.santheafrica.org. Retrieved 29 November 2021.
  5. "South African health experts have identified a new lineage of SARS-CoV-2: what's known so far". University of Pretoria. 26 January 2022. Retrieved 26 January 2022.
  6. Callaway, Ewen (25 November 2021). "Heavily mutated coronavirus variant puts scientists on alert". Nature. 600 (7887): 21. doi:10.1038/d41586-021-03552-w. PMID 34824381. S2CID 244660616.
  7. ^ "Professor Penny Moore received a Silver Medal from SAMRC". NICD. 12 September 2018. Retrieved 26 January 2022.
  8. "Annual Report - Director's Report" (PDF). p. 1. Retrieved 26 January 2022.
  9. "Who are the founding members?". The Mail & Guardian. 11 November 2011. Retrieved 26 January 2022.
  10. "Wits Research Matters" (PDF). University of the Witwatersrand. p. 32.
  11. "SAMRC to honour distinguished scientists at a 50th Gala Event". UCT Lung Institute. 8 November 2019. Retrieved 26 January 2022.
  12. ^ "MEMBERS". SAYAS. 10 September 2016. Retrieved 26 January 2022.

External links

Pre-pandemic
2020
2021
2022
2023 and after
Africa
Northern
Eastern
Southern
Central
Western
Asia
Central/North
East
Mainland China
South
India
By location
Southeast
Malaysia
Philippines
West
Europe
United Kingdom
By location
Eastern
Western Balkans
European Union
EFTA countries
Microstates
North
America
Atlantic
Canada
Caribbean
Countries
British Overseas Territories
Caribbean Netherlands
French West Indies
US insular areas
Central America
United States
responses
By location
Oceania
Australia
New Zealand
South
America
Others
Culture and
entertainment
Arts and
cultural heritage
Education
By country
Sports
By country
By sport
Society
and rights
Social impact
Labor
Human rights
Legal
Minority
Religion
Economic
By country
By industry
Supply and trade
Financial markets
Information
Misinformation
Politics
Political impact
Protests
International relations
Language
Others
Health issues
Medical topics
Testing and
epidemiology
Apps
Prevention
Vaccines
Topics
Authorized
DNA
Inactivated
mRNA
Subunit
Viral vector
Virus-like particles
In trials
Attenuated
DNA
Inactivated
RNA
Subunit
Viral vector
Virus-like particles
Deployment
by location
Africa
Asia
Europe
North America
Oceania
South America
Others
Treatment
Monoclonal antibodies
Small molecule antivirals
Specific
General
Institutions
Hospitals and
medical clinics
Mainland China
Others
Organizations
Global
By location
Health
institutes
Pandemic
institutes
Relief funds
People
Medical
professionals
Researchers
Officials
WHO
By location
Others
Deaths
Data (templates)
Global
Africa
Americas
Asia
Europe
Oceania
Others

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑